TotalMarketCap

Argenx Se

ARGXNasdaq NetherlandsHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$57.751 B

$930.52 +1.93%

Close of 7 Oct 2026

As of 7 Oct 2026, Argenx Se (ARGX) has a market capitalization of $57.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,883,306

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →
  1. #2Gilead SciencesGILD$178.8B
  2. #3ModernaMRNA$74.8B
  3. #4Argenx SeARGX$57.8B
  4. #5Revolution MedicinesRVMD$42.8B
  5. #6BiogenBIIB$32.9B

What if Argenx Se were worth as much as…

Open the what-if tool →

Gold $28.8T

$463,875.20

Per share 499× higher

Bitcoin $1.67T

$26,912.18

Per share 28.9× higher

Nvidia $5.77T

$92,900.67

Per share 99.8× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Argenx Se are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.